Mindfulness-Based Psychoeducation ProgramUsual Care
Mindfulness-Based Psychoeducation Program: The mindfulness-based psychoeducation program is designed to support psychological well-being and coping with cancer among women diagnosed with gynecological cancer. The program consists of eight weekly sessions conducted in small groups of approximately 4-5 participants and delivered through online platforms under the guidance of the researcher. The sessions include mindfulness-based practices such as breathing exercises, body scan meditation, awareness exercises, guided imagery, and reflective group discussions. The program aims to enhance participants' awareness of the present moment, improve emotional regulation, strengthen coping with cancer, and promote psychological well-being, hope, and quality of life.
Usual Care: Participants in the control group will receive usual care provided by the healthcare institution and will not participate in the mindfulness-based psychoeducation program during the study period.
Study summary
This randomized controlled study aims to evaluate the effect of a mindfulness-based psychoeducation program on hope, cognitive-emotional coping with cancer, quality of life, and psychological well-being in women diagnosed with gynecological cancer. Women receiving treatment for gynecological cancer will be randomly assigned to either an intervention group and a control group. The intervention group will participate in an 8-week mindfulness-based psychoeducation program delivered in small groups via online platforms under the guidance of the researcher. The program will include mindfulness practices such as breathing exercises, body scan, awareness exercises, and guided imagery techniques aimed at improving emotional coping and psychological well-being. The control group will receive usual care. Outcomes will be assessed at baseline, immediately after the intervention, and at 3- and 6-month follow-up assessments.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Women who voluntarily agree to participate in the study
* Women aged 18 years and older
* Women diagnosed with gynecological cancer and currently undergoing active treatment (e.g., surgery, chemotherapy, radiotherapy, immunotherapy, or targeted therapy)
* Ability to participate in online sessions from home after hospital discharge
* Ability to use a smartphone or similar device to access online sessions
* Having at least basic literacy (able to read and write)
* Expected life expectancy ≥ 12 months, as evaluated by the responsible oncologist
Exclusion Criteria:
* Diagnosis of a psychiatric disorder that may interfere with participation
* Current use of psychiatric medications
* Previous participation in Mindfulness-Based Stress Reduction (MBSR) or similar mindfulness programs
* Having a physical condition that prevents participation in the intervention sessions
* Presence of communication barriers (e.g., inability to speak Turkish, severe hearing impairment)
* Having a history of previous cancer diagnosis or metastatic disease
* Participants who voluntarily withdraw from the study during the intervention period
* Participation in less than 80% of the intervention sessions (attendance at fewer than 6 out of 8 sessions)
* Discontinuation of treatment or death during the study period
Primary outcome measure(s)
Hopelessness Measured by Beck Hopelessness Scale — Baseline, immediately after the intervention, 3 months, and 6 months follow-up Hopelessness will be assessed using the Beck Hopelessness Scale (BHS). The scale measures negative expectations about the future and pessimistic attitudes. Higher scores indicate greater levels of hopelessness among participants.
Cognitive-Emotional Coping with Cancer Scale Scores — Baseline, immediately after the intervention, 3 months, and 6 months follow-up Cognitive-emotional coping with cancer will be assessed using the Cognitive-Emotional Coping with Cancer Scale. Higher scores indicate more adaptive coping strategies among women diagnosed with gynecological cancer.
Quality of Life Measured by EORTC QLQ-C30 — Baseline, immediately after the 8-week intervention, 3 months, and 6 months after the intervention Quality of life will be assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). Higher scores on functional scales indicate better quality of life among women diagnosed with gynecological cancer.
Psychological Well-Being Measured by the Psychological Well-Being Scale — Baseline, immediately after the 8-week intervention, 3 months, and 6 months after the intervention Psychological well-being will be assessed using the Psychological Well-Being Scale. Higher scores indicate better psychological well-being among women diagnosed with gynecological cancer.
Trial sites (2)
Facility
City
Region
Status
Ondokuz Mayis University Health Practice and Research Center
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
